What do we know about memory B cells in primary Sjogren's syndrome?

被引:25
作者
Hansen, Arne [1 ,2 ]
Daridon, Capucine [3 ]
Doerner, Thomas [3 ]
机构
[1] Akad Lehrkrankenhaus Charite, Pk Klink Weissensee, Dept Med, D-13086 Berlin, Germany
[2] Charite, Outpatients Dept Med, Berlin, Germany
[3] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
关键词
Primary Sjogrens syndrome; Autoimmunity; Memory B cells; Lymphoma; Rituximab; DEPRESSED PERCENTAGE; AUTOIMMUNE-DISEASES; SALIVARY-GLANDS; BLOOD; EXPRESSION; RITUXIMAB; CD27; HETEROGENEITY; CORRELATE; LYMPHOMA;
D O I
10.1016/j.autrev.2010.05.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Abnormalities of memory B cells seem to be closely involved in the pathogenesis of primary Sjogrens Syndrome (pSS) and its malignant complication, B cell lymphoma. Recent studies on B cells in pSS add to our understanding of the distinct memory B cell subsets in pSS. Reduction of peripheral memory CD27(+) B cells, most strikingly of the CD27(+) IgM(+) subset, may indicate a lack of appropriate censoring mechanisms and Incomplete differentiation processes within the ectopic lymphoid tissues in pSS. This ectopically formed lymphoid tissue might protect autoreactive memory B cells from deletion by physiological check-points and, thereby, may contribute to the perpetuation of the disease as well as to an enhanced lymphoma risk. Thus, B cells may be potential targets of direct or indirect treatment in pSS (C) 2010 Elsevier B V All rights reserved
引用
收藏
页码:600 / 603
页数:4
相关论文
共 50 条
  • [11] B cells in Sjogren's syndrome: from pathophysiology to therapeutic target
    Mielle, Julie
    Tison, Alice
    Cornec, Divi
    Le Pottier, Laetitia
    Daien, Claire
    Pers, Jacques-Olivier
    RHEUMATOLOGY, 2021, 60 (06) : 2545 - 2560
  • [12] B cells in Sjogren's syndrome: From pathophysiology to diagnosis and treatment
    Cornec, Divi
    Devauchelle-Pensec, Valerie
    Tobon, Gabriel J.
    Pers, Jacques-Olivier
    Jousse-Joulin, Sandrine
    Saraux, Alain
    JOURNAL OF AUTOIMMUNITY, 2012, 39 (03) : 161 - 167
  • [13] Primary Sjogren's syndrome
    Rischmueller, Maureen
    Tieu, Joanna
    Lester, Susan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 189 - 220
  • [14] Rituximab Therapy for Primary Sjogren's Syndrome
    Chen, Yi Han
    Wang, Xin Yu
    Jin, Xin
    Yang, Zi
    Xu, Jianguang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [15] Merkel cell carcinoma: What do we know about it and what should we do?
    Prieto Munoz, Isabel
    Pardo Masferrer, Jose
    Olivera Vegas, Jesus
    Fortes Alen, Jose Ramon
    Perez Casas, Ana M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (06) : 401 - 412
  • [16] A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjogren's syndrome and systemic lupus erythematosus
    Szabo, K.
    Papp, G.
    Szanto, A.
    Tarr, T.
    Zeher, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 183 (01) : 76 - 89
  • [17] What Do We Know About Psychological Outcomes of Lymphoma in Adults?
    Mojs, Ewa
    Warchol-Biedermann, Katarzyna
    Samborski, Wlodzimierz
    EUROPEAN PSYCHOLOGIST, 2017, 22 (02) : 121 - 131
  • [18] Genetic platforms: Do we do what we know? or do we know what we do?
    Bernet, Laia
    Pla, Maria Jesus
    Janez, Noelia Martinez
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (02): : 100 - 110
  • [19] Epigenetic dysregulation in salivary glands from patients with primary Sjogren's syndrome may be ascribed to infiltrating B cells
    Thabet, Yosra
    Le Dantec, Christelle
    Ghedira, Ibtissem
    Devauchelle, Valerie
    Cornec, Divi
    Pers, Jacques-Olivier
    Renaudineau, Yves
    JOURNAL OF AUTOIMMUNITY, 2013, 41 : 175 - 181
  • [20] Rett syndrome: what do we know for sure?
    Zoghbi, Huda Y.
    NATURE NEUROSCIENCE, 2009, 12 (03) : 239 - 240